About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

25

Nov

2015

Healthcare Change: Mede National

Effective: January 1, 2016

Please find attached a REVISED copy of the Mede National / Mede Preferred vD.0 payer sheet.

 

Effective January 1, 2016, Mede National / Mede Preferred will no longer support Coordination of Benefits/Other Payments segment Scenario 1 (OPAP).

 

Instead Mede National / Mede Preferred will support Coordination of Benefits/Other Payments segment Scenario 2 (OPPRA).

 

25

Nov

2015

CVS/caremark: Medicare Part B vs. Medicare Part D Point-of-Service Assistance

SecureRx PDP

RXBIN: 004336

RXPCN: MEDDADV

RXGRP: RXCAP

As required by CVS/caremark, for drug products that potentially qualify under

Part B or Part D, a pharmacy provider must promptly obtain any necessary

information from the enrollee or prescriber to properly submit the drug for

processing (e.g., to the Part B plan or the Part D plan). Pursuant to your

Medicare Part D contract, it is the responsibility of the pharmacy provider to

determine whether the drug is a Part B or Part D covered drug. Only a drug that

is determined to be a Part D claim should be submitted under the Medicare Part

D program.

25

Nov

2015

CVS/caremark: Medicare Part B vs. Medicare Part D Point-of-Service Assistance

Capital BlueCross

RXBIN: 004336

RXPCN: MEDDADV

RXGRP: RXCAP

As required by CVS/caremark, for drug products that potentially qualify under

Part B or Part D, a pharmacy provider must promptly obtain any necessary

information from the enrollee or prescriber to properly submit the drug for

processing (e.g., to the Part B plan or the Part D plan). Pursuant to your

Medicare Part D contract, it is the responsibility of the pharmacy provider to

determine whether the drug is a Part B or Part D covered drug. Only a drug that

is determined to be a Part D claim should be submitted under the Medicare Part

D program.

25

Nov

2015

CVS/caremark: Formulary Update for Tyson Foods

Effective: January 1, 2016

RXBIN: 004336

RXPCN: ADV

RXGRP: RX2457

CVS/caremark administers the prescription benefits for Tyson Foods.

Prescription benefit change

Tyson Foods’ formulary will change effective January 1, 2016. This will result

in changes including, but not limited to, drug copays, tier changes, drug

exclusions, changes in allowed quantities, step therapy changes or additions,

and/or prior authorization additions.

24

Nov

2015

NCPA Survey: What's Important to You?

NCPA is asking members to tell them where to focus the majority of their time and energy serving the membership by filling out a short six-question survey which will take less than 10 minutes to complete.

First833835Last